
April McClain Delaney
DHouseRepresentative · Maryland
T
Sold up to $15,000 of Bio-Techne (TECH)
Trade dated Jan 28, 20265 days to disclose
TECH since the sale
-18.9%
S&P 500, same window
+8.9%
▼ TECH trailed the S&P 500 by 27.8 points since the sale
Price move from the trade date's close to the most recent close. A sale is favorable when the stock fell after.
⚑ Committee jurisdiction
April McClain Delaney sits on Research and Technology, which oversees the Healthcare sector. This trade fell in that sector while April McClain Delaney held the seat. STOCK Act trades are legal; this is a structural overlap on the public record.
On the public record around this trade
Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.
- Dec 17, 2025Floor voteResult: Passed
- Dec 18, 2025Floor voteResult: Failed
- Dec 18, 2025Floor voteResult: Passed
- Jan 13, 2026LegislationHealthcare sector
- Jan 21, 2026LegislationHealthcare sector
- Jan 28, 2026TradeSold up to $15,000 of TECH
- Jan 30, 2026LegislationHealthcare sector
- Feb 2, 2026DisclosureDisclosed the tradePublic filing
- Feb 2, 2026Floor voteResult: Passed
- Feb 3, 2026Floor voteResult: Passed
- Feb 11, 2026LegislationHealthcare sector
- Feb 12, 2026LegislationHealthcare sector
Get an alert the moment April McClain Delaney files the next one
Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.